Article

Fully Integrated downstream process to enable Next Generation Manufacturing

2022-10-03

Abstract excerpt

Next generation manufacturing (NGM) has evolved over the past decade to a point where large biopharmaceutical organizations are making large investments in the technology and considering implementation in clinical and commercial processes. There are many well-considered reasons to implement NGM. For the most part, organizations will not fund NGM unless the implementation benefits the funding organization by provid...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b7455c3f-a06b-5d5f-83ee-54df9685e4e0
DOI: 10.22541/au.166482543.39123807/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Fully Integrated downstream process to enable Next Generation ManufacturingDOI 10.22541/au.166482543.39123807/v1Read

Towards a commercial process for the manufacture of genetically modified T cells for therapySemantic proximity Read

A comparison of different intensified upstream processes highlighting the advantage of WuXiUP in improved product quality and simplified downstream processSemantic proximity Read

Status and future developments for downstream processing of biological products Perspectives from the Recovery XIX yield roundtable discussionsSemantic proximity Read

Impact of fed-batch process intensification on the productivity and product quality of two CHO cell lines expressing unique novel molecular format proteinsSemantic proximity Read

2-D DIGE to expedite downstream process development for human monoclonal antibody purificationSemantic proximity Read

Assessing the Manufacturability and Critical Quality Attribute Profiles of Anti-IL-8 Immunoglobulin G Mutant Variants.Semantic proximity Read

GMP manufacturing of cell and gene therapy products: Challenges, opportunities, and pathways forwardSemantic proximity Read

Host Cell Proteins in Biologics Manufacturing: The Good, the Bad, and the UglySemantic proximity Read

Reshaping Cell Line Development and CMC Strategy for Fast Responses to Pandemic OutbreakSemantic proximity Read

The Role of the Biomanufacturing Industry in Developing Diagnostics and mRNA Vaccines Against COVID-19Semantic proximity Read

Towards Non-destructive Quality Testing of Complex Biomedical Devices – a Generalized Closed Loop System Approach Utilizing Real-Time in Line Process Analytical TechnologySemantic proximity Read

Process Development and Scale-up Optimization of the SARS-CoV-2 Receptor Binding Domain-Based Vaccine Candidate, RBD219-N1C1Semantic proximity Read